サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1546239

放射線量管理の世界市場

Radiation Dose Management

出版日
ページ情報
英文 179 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
放射線量管理の世界市場
出版日: 2024年09月03日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 179 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

放射線量管理の世界市場は2030年までに8億3,520万米ドルに達する見込み

2023年に3億4,110万米ドルと推定される放射線量管理の世界市場は、2030年には8億3,520万米ドルに達し、分析期間2023-2030年のCAGRは13.6％で成長すると予測されます。本レポートで分析したセグメントの1つである放射線量管理ソリューションは、CAGR 14.0％を記録し、分析期間終了時には4億7,960万米ドルに達すると予測されます。放射線量管理サービス分野の成長率は、分析期間でCAGR 13.2％と推定されます。

米国市場は9,200万米ドルと推定、中国はCAGR 12.7%で成長すると予測

米国の放射線量管理市場は、2023年に9,200万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2023-2030年のCAGR12.7%で推移し、2030年までに1億2,630万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ12.3％と11.3％と予測されています。欧州では、ドイツがCAGR約9.8%で成長すると予測されています。

世界の放射線量管理市場- 主要動向と促進要因まとめ

放射線量管理：医療画像診断における患者の安全確保

放射線量管理とは、X線、CTスキャン、核医学などの医療用画像処理で患者が受ける放射線被ばく量を監視、管理、最適化するための体系的なアプローチを指します。このプロセスは、正確な医学的評価に必要な診断の質を達成しつつ、患者の安全を確保するために極めて重要です。過剰な放射線被ばくは、がんなどの健康への悪影響のリスクを高める可能性があり、診断情報の完全性を維持しながら被ばくを最小限に抑えることが不可欠です。放射線量管理システムは、放射線量を追跡し、医療従事者に過度の被曝の可能性を警告し、放射線使用を最適化するためのベストプラクティスを実施するように設計されています。このようなシステムの導入は、画像診断の利用が世界的に増加し続ける中、ますます重要になってきています。

技術の進歩は放射線量管理をどのように向上させているか？

技術の進歩により、放射線量管理システムは大幅に改善され、より効率的で精度が高く、ヘルスケアのワークフローに統合されました。最新のシステムには、放射線量データをリアルタイムで解析する高度な解析と機械学習アルゴリズムが組み込まれており、ヘルスケアプロバイダーに即座にフィードバックを提供します。これらのシステムは、患者の体格、年齢、特定の診断要件に基づいて撮影プロトコルを自動的に調整できるため、画質を損なうことなく不必要な被ばくを最小限に抑えることができます。放射線量管理システムと電子カルテ（EHR）を統合することで、患者の放射線履歴をシームレスに記録・追跡することができ、今後の画像診断について、より個別化された情報に基づいた判断が可能になります。さらに、線量最適化ソフトウェアの進歩により、異なる撮影機器間でプロトコルを標準化することが可能になり、ヘルスケア施設全体での放射線管理の一貫性が確保されています。このような技術的改善により、高度な放射線量管理システムの導入が促進され、患者の安全性が向上し、医療画像診断の治療成績が改善されています。

医療画像診断における放射線量管理の主な用途と利点とは？

放射線量管理システムは、様々な画像診断モダリティで活用され、患者の安全性、規制基準への準拠、ヘルスケア全体の質を高める数多くのメリットを提供しています。放射線診断では、他の画像技術に比べて放射線量が比較的高いことで知られるCTスキャン時の放射線被ばくをモニターし、低減するのに役立ちます。長時間の被ばくを伴うことが多いインターベンショナルラジオロジーでは、放射線量管理は患者とヘルスケアスタッフを過剰な放射線から守るために不可欠です。また、小児は放射線に対する感受性が高いため、放射線被曝を最小限に抑えることが特に重要な小児画像診断においても、放射線量管理は威力を発揮します。さらに、放射線量管理システムは、国際原子力機関（IAEA）や欧州原子力共同体（Euratom）のような国際的な基準や規制への準拠をサポートし、ヘルスケアプロバイダーが安全要件を満たすことを保証します。放射線量管理の主な利点には、患者の安全性の向上、臨床上の意思決定の改善、放射線誘発性合併症のリスク低減などがあり、現代の医療画像診断に不可欠な要素となっています。

放射線量管理市場の成長を促進する要因は？

放射線量管理市場の成長は、いくつかの要因によって牽引されています。医療従事者や患者の間で放射線安全に対する意識が高まっており、医療画像撮影時の放射線被ばくを最小限に抑えることに重点が置かれていることが大きな促進要因となっています。また、線量管理ソフトウェア、データ解析、機械学習などの技術進歩も、これらのシステムの精度と効率を向上させることで市場成長を後押ししています。特に高齢化社会における世界の画像診断件数の増加は、放射線量管理ソリューションの需要をさらに押し上げています。さらに、放射線安全に関する厳しい規制要件や認定基準が市場の成長に寄与しています。ヘルスケアプロバイダーは、高度な線量管理システムを導入することでこれらの規制を遵守しようとしているからです。また、電子カルテ（EHR）の普及が進み、線量管理システムがEHRに統合されるようになったことも、市場の拡大を後押ししています。これらの要因が、ヘルスケア技術の継続的な革新と相まって、放射線量管理市場の持続的成長を後押ししています。

調査対象企業の例（全11件）

  • Agfa HealthCare
  • Bayer AG
  • Bracco Imaging SpA
  • FUJIFILM Holdings Corporation
  • GE Healthcare
  • Medsquare
  • Novarad Corporation
  • PACSHealth LLC
  • Philips Healthcare
  • Qaelum N.V.
  • Sectra AB
  • Siemens Healthineers

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP14319

Global Radiation Dose Management Market to Reach US$835.2 Million by 2030

The global market for Radiation Dose Management estimated at US$341.1 Million in the year 2023, is expected to reach US$835.2 Million by 2030, growing at a CAGR of 13.6% over the analysis period 2023-2030. Radiation Dose Management Solutions, one of the segments analyzed in the report, is expected to record a 14.0% CAGR and reach US$479.6 Million by the end of the analysis period. Growth in the Radiation Dose Management Services segment is estimated at 13.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$92.0 Million While China is Forecast to Grow at 12.7% CAGR

The Radiation Dose Management market in the U.S. is estimated at US$92.0 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$126.3 Million by the year 2030 trailing a CAGR of 12.7% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 12.3% and 11.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 9.8% CAGR.

Global Radiation Dose Management Market - Key Trends and Drivers Summarized

Radiation Dose Management: Ensuring Patient Safety in Medical Imaging

Radiation dose management refers to the systematic approach to monitoring, controlling, and optimizing the amount of radiation exposure patients receive during medical imaging procedures such as X-rays, CT scans, and nuclear medicine. This process is crucial in ensuring patient safety while achieving the diagnostic quality necessary for accurate medical evaluations. Excessive radiation exposure can increase the risk of adverse health effects, including cancer, making it essential to minimize exposure while maintaining the integrity of the diagnostic information. Radiation dose management systems are designed to track radiation doses, alert healthcare providers to potentially excessive exposure levels, and implement best practices to optimize radiation use. The implementation of these systems is becoming increasingly important as the use of diagnostic imaging continues to grow worldwide.

How Are Technological Advancements Enhancing Radiation Dose Management?

Technological advancements have significantly improved radiation dose management systems, making them more efficient, precise, and integrated into healthcare workflows. Modern systems now incorporate advanced analytics and machine learning algorithms that analyze radiation dose data in real-time, providing immediate feedback to healthcare providers. These systems can automatically adjust imaging protocols based on patient size, age, and the specific diagnostic requirement, thereby minimizing unnecessary exposure without compromising image quality. The integration of radiation dose management systems with electronic health records (EHRs) allows for seamless documentation and tracking of patient radiation histories, enabling more personalized and informed decisions about future imaging procedures. Additionally, advancements in dose optimization software have made it possible to standardize protocols across different imaging devices, ensuring consistency in radiation management across a healthcare facility. These technological improvements are driving the adoption of sophisticated radiation dose management systems, enhancing patient safety and improving outcomes in medical imaging.

What Are the Key Applications and Benefits of Radiation Dose Management in Medical Imaging?

Radiation dose management systems are utilized across various imaging modalities, offering numerous benefits that enhance patient safety, compliance with regulatory standards, and overall healthcare quality. In diagnostic radiology, these systems help monitor and reduce radiation exposure during CT scans, which are known for their relatively high radiation doses compared to other imaging techniques. In interventional radiology, where procedures often involve prolonged exposure times, radiation dose management is critical for protecting both patients and healthcare staff from excessive radiation. The systems are also valuable in pediatric imaging, where minimizing radiation exposure is particularly important due to the increased sensitivity of children to radiation. Furthermore, radiation dose management systems support compliance with international standards and regulations, such as those set by the International Atomic Energy Agency (IAEA) and the European Atomic Energy Community (Euratom), ensuring that healthcare providers meet safety requirements. The primary benefits of radiation dose management include enhanced patient safety, improved clinical decision-making, and reduced risk of radiation-induced complications, making it an essential component of modern medical imaging practices.

What Factors Are Driving the Growth in the Radiation Dose Management Market?

The growth in the Radiation Dose Management market is driven by several factors. The increasing awareness of radiation safety among healthcare providers and patients is a significant driver, as more emphasis is placed on minimizing radiation exposure during medical imaging. Technological advancements in dose management software, data analytics, and machine learning are also propelling market growth by improving the precision and efficiency of these systems. The rising number of diagnostic imaging procedures worldwide, particularly in aging populations, is further boosting demand for radiation dose management solutions, as these systems are essential for ensuring patient safety in high-volume imaging environments. Additionally, stringent regulatory requirements and accreditation standards related to radiation safety are contributing to market growth, as healthcare providers seek to comply with these regulations by implementing advanced dose management systems. The growing adoption of electronic health records (EHRs) and the integration of dose management systems with EHRs are also supporting market expansion, as these technologies enable better tracking and optimization of radiation exposure. These factors, combined with continuous innovation in healthcare technology, are driving the sustained growth of the Radiation Dose Management market.

Select Competitors (Total 11 Featured) -

  • Agfa HealthCare
  • Bayer AG
  • Bracco Imaging SpA
  • FUJIFILM Holdings Corporation
  • GE Healthcare
  • Medsquare
  • Novarad Corporation
  • PACSHealth LLC
  • Philips Healthcare
  • Qaelum N.V.
  • Sectra AB
  • Siemens Healthineers

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Radiation Dose Management - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Focus on Patient Safety and Radiation Protection Propels Market Growth
    • Technological Advancements in Dose Tracking and Monitoring Software Strengthen Market Position
    • Growing Adoption of Digital Health Records Drives Integration of Dose Management Systems
    • Surge in Demand for Dose Management Solutions in Diagnostic Imaging Generates New Opportunities
    • Development of AI and Machine Learning-Based Dose Optimization Sustains Market Growth
    • Expanding Applications in Interventional Radiology Throws Spotlight on Market Potential
    • Growth in Radiology Practices and Imaging Centers Spurs Demand for Dose Management
    • Increasing Awareness of Radiation-Induced Health Risks Strengthens Business Case
    • Rising Adoption of Cloud-Based Dose Management Solutions Propels Market Expansion
    • Surge in Demand for Automated Dose Monitoring in Radiation Therapy Expands Market Horizons
    • Growing Emphasis on Compliance with International Radiation Safety Standards Drives Market Adoption
    • Innovations in Real-Time Dose Monitoring and Reporting Generate New Market Opportunities
    • Rising Demand for Dose Management in Pediatric and Geriatric Imaging Throws Spotlight on Market Dynamics
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Computed Tomography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 2: World 7-Year Perspective for Computed Tomography by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 3: World Recent Past, Current & Future Analysis for Radiography & Mammography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 4: World 7-Year Perspective for Radiography & Mammography by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Nuclear Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 6: World 7-Year Perspective for Nuclear Medicine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 8: World 7-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 9: World Recent Past, Current & Future Analysis for Ambulatory Care Settings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 10: World 7-Year Perspective for Ambulatory Care Settings by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 11: World Radiation Dose Management Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Radiation Dose Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 13: World 7-Year Perspective for Radiation Dose Management by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Solutions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 15: World 7-Year Perspective for Solutions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 17: World 7-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Fluoroscopy & Interventional Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 19: World 7-Year Perspective for Fluoroscopy & Interventional Imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 21: World 7-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Radiation Dose Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 22: USA Recent Past, Current & Future Analysis for Radiation Dose Management by Modality - Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 23: USA 7-Year Perspective for Radiation Dose Management by Modality - Percentage Breakdown of Value Sales for Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography for the Years 2024 & 2030
    • TABLE 24: USA Recent Past, Current & Future Analysis for Radiation Dose Management by End-Use - Hospitals, Ambulatory Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 25: USA 7-Year Perspective for Radiation Dose Management by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Care Settings and Other End-Uses for the Years 2024 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Radiation Dose Management by Component - Solutions and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA 7-Year Perspective for Radiation Dose Management by Component - Percentage Breakdown of Value Sales for Solutions and Services for the Years 2024 & 2030
  • CANADA
    • TABLE 28: Canada Recent Past, Current & Future Analysis for Radiation Dose Management by Modality - Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 29: Canada 7-Year Perspective for Radiation Dose Management by Modality - Percentage Breakdown of Value Sales for Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography for the Years 2024 & 2030
    • TABLE 30: Canada Recent Past, Current & Future Analysis for Radiation Dose Management by End-Use - Hospitals, Ambulatory Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 31: Canada 7-Year Perspective for Radiation Dose Management by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Care Settings and Other End-Uses for the Years 2024 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Radiation Dose Management by Component - Solutions and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada 7-Year Perspective for Radiation Dose Management by Component - Percentage Breakdown of Value Sales for Solutions and Services for the Years 2024 & 2030
  • JAPAN
    • Radiation Dose Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 34: Japan Recent Past, Current & Future Analysis for Radiation Dose Management by Modality - Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 35: Japan 7-Year Perspective for Radiation Dose Management by Modality - Percentage Breakdown of Value Sales for Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography for the Years 2024 & 2030
    • TABLE 36: Japan Recent Past, Current & Future Analysis for Radiation Dose Management by End-Use - Hospitals, Ambulatory Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 37: Japan 7-Year Perspective for Radiation Dose Management by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Care Settings and Other End-Uses for the Years 2024 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Radiation Dose Management by Component - Solutions and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Japan 7-Year Perspective for Radiation Dose Management by Component - Percentage Breakdown of Value Sales for Solutions and Services for the Years 2024 & 2030
  • CHINA
    • Radiation Dose Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 40: China Recent Past, Current & Future Analysis for Radiation Dose Management by Modality - Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 41: China 7-Year Perspective for Radiation Dose Management by Modality - Percentage Breakdown of Value Sales for Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography for the Years 2024 & 2030
    • TABLE 42: China Recent Past, Current & Future Analysis for Radiation Dose Management by End-Use - Hospitals, Ambulatory Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 43: China 7-Year Perspective for Radiation Dose Management by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Care Settings and Other End-Uses for the Years 2024 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Radiation Dose Management by Component - Solutions and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: China 7-Year Perspective for Radiation Dose Management by Component - Percentage Breakdown of Value Sales for Solutions and Services for the Years 2024 & 2030
  • EUROPE
    • Radiation Dose Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 46: Europe Recent Past, Current & Future Analysis for Radiation Dose Management by Modality - Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 47: Europe 7-Year Perspective for Radiation Dose Management by Modality - Percentage Breakdown of Value Sales for Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography for the Years 2024 & 2030
    • TABLE 48: Europe Recent Past, Current & Future Analysis for Radiation Dose Management by End-Use - Hospitals, Ambulatory Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 49: Europe 7-Year Perspective for Radiation Dose Management by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Care Settings and Other End-Uses for the Years 2024 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Radiation Dose Management by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe 7-Year Perspective for Radiation Dose Management by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2024 & 2030
    • TABLE 52: Europe Recent Past, Current & Future Analysis for Radiation Dose Management by Component - Solutions and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 53: Europe 7-Year Perspective for Radiation Dose Management by Component - Percentage Breakdown of Value Sales for Solutions and Services for the Years 2024 & 2030
  • FRANCE
    • Radiation Dose Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 54: France Recent Past, Current & Future Analysis for Radiation Dose Management by Modality - Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 55: France 7-Year Perspective for Radiation Dose Management by Modality - Percentage Breakdown of Value Sales for Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography for the Years 2024 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Radiation Dose Management by End-Use - Hospitals, Ambulatory Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: France 7-Year Perspective for Radiation Dose Management by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Care Settings and Other End-Uses for the Years 2024 & 2030
    • TABLE 58: France Recent Past, Current & Future Analysis for Radiation Dose Management by Component - Solutions and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 59: France 7-Year Perspective for Radiation Dose Management by Component - Percentage Breakdown of Value Sales for Solutions and Services for the Years 2024 & 2030
  • GERMANY
    • Radiation Dose Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 60: Germany Recent Past, Current & Future Analysis for Radiation Dose Management by Modality - Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 61: Germany 7-Year Perspective for Radiation Dose Management by Modality - Percentage Breakdown of Value Sales for Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography for the Years 2024 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Radiation Dose Management by End-Use - Hospitals, Ambulatory Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Germany 7-Year Perspective for Radiation Dose Management by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Care Settings and Other End-Uses for the Years 2024 & 2030
    • TABLE 64: Germany Recent Past, Current & Future Analysis for Radiation Dose Management by Component - Solutions and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 65: Germany 7-Year Perspective for Radiation Dose Management by Component - Percentage Breakdown of Value Sales for Solutions and Services for the Years 2024 & 2030
  • ITALY
    • TABLE 66: Italy Recent Past, Current & Future Analysis for Radiation Dose Management by Modality - Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 67: Italy 7-Year Perspective for Radiation Dose Management by Modality - Percentage Breakdown of Value Sales for Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography for the Years 2024 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Radiation Dose Management by End-Use - Hospitals, Ambulatory Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Italy 7-Year Perspective for Radiation Dose Management by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Care Settings and Other End-Uses for the Years 2024 & 2030
    • TABLE 70: Italy Recent Past, Current & Future Analysis for Radiation Dose Management by Component - Solutions and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 71: Italy 7-Year Perspective for Radiation Dose Management by Component - Percentage Breakdown of Value Sales for Solutions and Services for the Years 2024 & 2030
  • UNITED KINGDOM
    • Radiation Dose Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 72: UK Recent Past, Current & Future Analysis for Radiation Dose Management by Modality - Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 73: UK 7-Year Perspective for Radiation Dose Management by Modality - Percentage Breakdown of Value Sales for Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography for the Years 2024 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Radiation Dose Management by End-Use - Hospitals, Ambulatory Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: UK 7-Year Perspective for Radiation Dose Management by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Care Settings and Other End-Uses for the Years 2024 & 2030
    • TABLE 76: UK Recent Past, Current & Future Analysis for Radiation Dose Management by Component - Solutions and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 77: UK 7-Year Perspective for Radiation Dose Management by Component - Percentage Breakdown of Value Sales for Solutions and Services for the Years 2024 & 2030
  • REST OF EUROPE
    • TABLE 78: Rest of Europe Recent Past, Current & Future Analysis for Radiation Dose Management by Modality - Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 79: Rest of Europe 7-Year Perspective for Radiation Dose Management by Modality - Percentage Breakdown of Value Sales for Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography for the Years 2024 & 2030
    • TABLE 80: Rest of Europe Recent Past, Current & Future Analysis for Radiation Dose Management by End-Use - Hospitals, Ambulatory Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Rest of Europe 7-Year Perspective for Radiation Dose Management by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Care Settings and Other End-Uses for the Years 2024 & 2030
    • TABLE 82: Rest of Europe Recent Past, Current & Future Analysis for Radiation Dose Management by Component - Solutions and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 83: Rest of Europe 7-Year Perspective for Radiation Dose Management by Component - Percentage Breakdown of Value Sales for Solutions and Services for the Years 2024 & 2030
  • ASIA-PACIFIC
    • Radiation Dose Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 84: Asia-Pacific Recent Past, Current & Future Analysis for Radiation Dose Management by Modality - Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 85: Asia-Pacific 7-Year Perspective for Radiation Dose Management by Modality - Percentage Breakdown of Value Sales for Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography for the Years 2024 & 2030
    • TABLE 86: Asia-Pacific Recent Past, Current & Future Analysis for Radiation Dose Management by End-Use - Hospitals, Ambulatory Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Asia-Pacific 7-Year Perspective for Radiation Dose Management by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Care Settings and Other End-Uses for the Years 2024 & 2030
    • TABLE 88: Asia-Pacific Recent Past, Current & Future Analysis for Radiation Dose Management by Component - Solutions and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 89: Asia-Pacific 7-Year Perspective for Radiation Dose Management by Component - Percentage Breakdown of Value Sales for Solutions and Services for the Years 2024 & 2030
  • REST OF WORLD
    • TABLE 90: Rest of World Recent Past, Current & Future Analysis for Radiation Dose Management by Modality - Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 91: Rest of World 7-Year Perspective for Radiation Dose Management by Modality - Percentage Breakdown of Value Sales for Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography for the Years 2024 & 2030
    • TABLE 92: Rest of World Recent Past, Current & Future Analysis for Radiation Dose Management by End-Use - Hospitals, Ambulatory Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of World 7-Year Perspective for Radiation Dose Management by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Care Settings and Other End-Uses for the Years 2024 & 2030
    • TABLE 94: Rest of World Recent Past, Current & Future Analysis for Radiation Dose Management by Component - Solutions and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 95: Rest of World 7-Year Perspective for Radiation Dose Management by Component - Percentage Breakdown of Value Sales for Solutions and Services for the Years 2024 & 2030

IV. COMPETITION